Healthcare entity

Scott Yang

Person

medical-devices is the sole category represented across all 1 tracked stories. 300U Tubeless Patch Pump is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline.

Last mentioned: Jul 27, 2026

Entity pulse

Recent coverage · Scott Yang

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Scott Yang

medical-devices is the sole category represented across all 1 tracked stories. 300U Tubeless Patch Pump is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window. We currently track 1 Healthcare story that mention Scott Yang, all published on July 27, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Scott Yang. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Scott Yang 1

Medical Devices Positive

Medtrum's 300U Patch Pump Gets German Reimbursement Code: 50% Capacity Boost

Medtrum's 300U tubeless insulin pump has been listed in Germany's statutory medical aids directory, a key step for reimbursement. The device offers 50% greater insulin capacity than standard patch pumps, potentially reducing device changes for high-dose patients. Healthcare providers and payers will weigh its integrated AID algorithm and real-world evidence as it moves toward commercial launch.

2 sources

Scott Yang is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.